X4 Pharmaceuticals XFOR
NASDAQ XFOR
$3.20 +0.19 (+6.31%)
At close: Oct 22, 2026 · 4:00 PM EDT

X4 Pharmaceuticals (XFOR) Total Non-Current Liabilities (2017 - 2026)

Updated

X4 Pharmaceuticals (XFOR) recorded Total Non-Current Liabilities of $97.09 million in Q2 2026, down 3.6% from $100.66 million a year earlier and down 3.8% from the prior quarter.

Analysis

X4 Pharmaceuticals (XFOR) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, X4 Pharmaceuticals reported Total Non-Current Liabilities of $103.19 million, down 6.6% from FY2024.

  • Annual Total Non-Current Liabilities has a five-year compound annual growth rate of 15.8% (FY2020 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $110.54 million in FY2024 (+37.4%), $80.48 million in FY2023 (+37.8%), $58.4 million in FY2022 (+12.4%) and $51.94 million in FY2021 (+4.7%).
  • The Q2 2026 figure is the lowest quarterly Total Non-Current Liabilities since Q1 2024.
  • On a year-over-year basis, Total Non-Current Liabilities has declined for five consecutive quarters, with growth averaging 8.5% over the last eight quarters.
  • Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 82.2% in Q2 2024, against a decline of 11.2% in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $100.93 million (Q1 2026), $103.19 million (Q4 2025) and $100.98 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 102.65 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 106.45 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 33.91 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 35.10 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 97.04 Bn
10 X4 Pharmaceuticals 405.56 Mn -293.12 Mn 7.19 Mn 96.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 96.72 Mn
Mar 31, 2026 100.41 Mn
Dec 31, 2025 102.67 Mn
Sep 30, 2025 100.45 Mn
Jun 30, 2025 100.38 Mn
Mar 31, 2025 103.58 Mn
Dec 31, 2024 109.70 Mn
Sep 30, 2024 106.24 Mn
Jun 30, 2024 105.96 Mn
Mar 31, 2024 80.68 Mn
Dec 31, 2023 80.04 Mn
Sep 30, 2023 82.60 Mn
Jun 30, 2023 57.21 Mn
Mar 31, 2023 54.69 Mn
Dec 31, 2022 58.23 Mn
Sep 30, 2022 51.25 Mn
Jun 30, 2022 50.63 Mn
Mar 31, 2022 49.26 Mn
Dec 31, 2021 51.94 Mn
Sep 30, 2021 51.34 Mn
API Access

X4 Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=XFOR&period=max&api_key=YOUR_API_KEY